Open-Label Study of a Twice-Daily Indinavir 800-mg/Ritonavir 100-mg Regimen in Protease Inhibitor-Naive HIV-Infected Adults.
Autor: | Young, Benjamin, Fischl, Margaret A., Wilson, Helene M., Finn, Tyler S., Jensen, Erin H., DiNubile, Mark J., Zeldin, Robert K. |
---|---|
Zdroj: | JAIDS: Journal of Acquired Immune Deficiency Syndromes; 12/15/2002, Vol. 31 Issue 5, p478, 5p, 2 Charts, 5 Graphs |
Databáze: | Complementary Index |
Externí odkaz: |